Postprandial metabolism: from research to clinical practice

References

• Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298, 299–308 (2007).
   Google Scholar
• Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 300, 2142–2152 (2008).
   Google Scholar
• Kolovou GD, Mikhailidis DP, Kovar J et al. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr. Vasc. Pharmacol. 9, 258–270 (2011).
   Google Scholar
• Chapman MJ, Ginsberg HN, Amarenco P et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur. Heart. J. 32, 1345–1361 (2011).
   Google Scholar
• Pérez-Martínez P, Moreno-Conde M, Cruz-Teno C et al. Dietary fat differentially influences regulatory endothelial function during the postprandial state in patients with metabolic syndrome: from the LIPGENE study. Atherosclerosis 209, 533–538 (2010).
   Google Scholar
• Pérez-Martínez P, Garcia-Quintana JM, Yubero-Serrano EM et al. Postprandial oxidative stress is modified by dietary fat: evidence from a human intervention study. Clin. Sci. (Lond.) 119, 251–261 (2010).
   Google Scholar
• van Oostrom AJ, Rabelink TJ, Verseyden C et al. Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis 177, 175–182 (2004).
   Google Scholar
• Pérez-Martínez P, Lopez-Miranda J, Blanco-Colio L et al. The chronic intake of a Mediterranean diet enriched in virgin olive oil, decreases nuclear transcription factor kappaB activation in peripheral blood mononuclear cells from healthy men. Atherosclerosis 194, e141–e146 (2007).
   Google Scholar
• Cruz-Teno C, Pérez-Martínez P, Delgado-Lista J et al. Dietary fat modifies the postprandial inflammatory state in subjects with metabolic syndrome: the LIPGENE study. Mol. Nutr. Food Res. 56, 854–865 (2012).
   Google Scholar
• Delgado-Lista J, Lopez-Miranda J, Cortés B et al. Chronic dietary fat intake modifies the postprandial response of hemostatic markers to a single fatty test meal. Am. J. Clin. Nutr. 87, 317–322 (2008).
   Google Scholar
• Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 86, 1286–1292 (2007).
   Google Scholar
• Clemente-Postigo M, Queipo-Ortuño MI, Murri M et al. Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients. J. Lipid Res. 53, 973–978 (2012).
   Google Scholar
• Pérez-Martínez P, Lopez-Miranda J, Perez-Jimenez F, Ordovas JM. Influence of genetic factors in the modulation of postprandial lipemia. Atheroscler Suppl. 9, 49–55 (2008).
   Google Scholar
• Pérez-Martínez P, Delgado-Lista J, Perez-Jimenez F, Lopez-Miranda J. Update on genetics of postprandial lipemia. Atheroscler. Suppl. 11, 39–43 (2010).
   Google Scholar
• Pérez-Martínez P, Garcia-Rios A, Delgado-Lista J, Perez-Jimenez F, Lopez-Miranda J. Nutrigenetics of the postprandial lipoprotein metabolism: evidences from human intervention studies. Curr. Vasc. Pharmacol. 9, 287–291 (2011).
   Google Scholar
• Kolovou GD, Kostakou PM, Anagnostopoulou KK, Cokkinos DV. Therapeutic effects of fibrates in postprandial lipemia. Am. J. Cardiovasc. Drugs 8, 243–255 (2008).
   Google Scholar
• Rizzo M, Christ ER, Rini GB, Spinas GA, Berneis K. The differential effects of thiazolidindiones on atherogenic dyslipidemia in Type-2 diabetes: what is the clinical significance? Expert Opin. Pharmacother. 9, 2295–2303 (2008).
   Google Scholar
• Berneis K, Rizzo M, Stettler C et al. Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial lowdensity lipopotein size and subclasses in patients with Type-2 diabetes. Expert Opin. Pharmacother. 9, 343–349 (2008).
   Google Scholar
• Rizzo M, Vekic J, Koulouris S, Zeljkovic A et al. Effects of rosiglitazone on fasting and postprandial low- and high-density lipoproteins size and subclasses in Type 2 diabetes. Angiology 61, 584–590 (2010).
   Google Scholar
• Rizzo M, Mikhailidis DP. There is more to predicting vascular disease than just established risk factors. Curr. Pharm. Des. 17, 3608–3610 (2011).
   Google Scholar
• Mikhailidis DP, Elisaf M, Rizzo M et al. “European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Curr. Vasc. Pharmacol. 9, 533–571 (2011).
   Google Scholar
• Mikhailidis DP, Elisaf MS, Rizzo M et al. “European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. Curr. Vasc. Pharmacol. 9, 531 (2011).
   Google Scholar
• Chan DC, Pang J, Romic G, Watts GF. Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies. Curr. Atheroscler. Rep. 15, 309 (2013).
   Google Scholar
• Rizzo M, Rizvi AA, Spinas GA, Rini GB, Berneis K. Glucose lowering and antiatherogenic effects of incretin-based therapies: GLP-1 analogues and DPP4-inhibitors. Expert Opin. Invest. Drugs 18, 1495–1503 (2009).
   Google Scholar
• Rizzo M. Lomitapide, a microsomal triglyceride transfer protein inhibitor for the treatment of hypercholesterolemia. IDrugs 13, 103–111 (2010).
   Google Scholar
• Rizzo M, Wierzbicki AS. New lipid modulating drugs: the role of microsomal transport protein inhibitors. Curr. Pharm. Des. 17, 943–949 (2011).
   Google Scholar
• Rizzo M, Nikolic D, Banach M et al. The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. Clin. Lipidol. 8, 173–181 (2013).
   Google Scholar